Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
19 nov. 2024 01h00 HE
|
Biogen Inc.
Dapirolizumab pegol (DZP) met its primary endpoint, demonstrating statistically and clinically significant improvement across all organ systems as measured by BICLA, an endpoint measuring disease...
Alumis Presents Data Highlighting ESK-001’s Potential as a High-efficacy Oral Treatment for Systemic Lupus Erythematosus (SLE) at ACR Convergence 2024
14 nov. 2024 16h05 HE
|
Alumis Inc.
Data at ACR for ESK-001, oral TYK2 inhibitor, demonstrates potential as a high efficacy oral for treatment of Systemic Lupus Erythematosus (SLE).
Sobi to present new data across its immunology portfolio at the ACR Convergence 2024
07 nov. 2024 06h59 HE
|
Sobi, Inc.
WALTHAM, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced the presentation of four abstracts that...
Zefiro Registers its First Methane Reduction Project on American Carbon Registry
29 avr. 2024 09h00 HE
|
Zefiro Methane Corp
FORT LAUDERDALE, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (the “Company”, “Zefiro”, or “ZEFI”) is pleased to announce that it has successfully completed its...
Automatic Content Recognition Market Report 2023-2030 - Rising Use of Audio Content Recognition Systems for Preventing Copyright Infringement is Fueling the Segment's Growth
12 déc. 2023 04h23 HE
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "Automatic Content Recognition Market Size, Share & Trends Analysis Report By Component (Software, Services), By Content, By Platform, By...
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
13 nov. 2023 08h00 HE
|
aTyr Pharma, Inc.
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its...
Zefiro Methane Corp. Co-Hosts U.S. Department of the Interior & New York State Officials at Successfully Plugged Oil Well Site
26 oct. 2023 14h11 HE
|
Zefiro Methane Corp
SOUTH WALES, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (the “Company”, “Zefiro”, or “ZEFI”) which works to reduce methane emissions by plugging orphaned oil and gas wells across...
Zefiro Head of Operations Matthew Brooks Presents on Carbon Credits Panel at Major Oil & Gas Conference in Houston, Texas
05 oct. 2023 09h00 HE
|
Zefiro Methane Corp
With unique expertise in acquisitions and divestitures in the U.S. oil and gas industry from both legal and operational perspectives, Mr. Brooks was chosen to speak on a panel at an industry...
Zefiro Methane Corp. & X Machina Capital Strategies to Co-Host 2023 NYC Climate Week Event
21 sept. 2023 11h32 HE
|
Zefiro Methane Corp
BRADFORD, Pa., Sept. 21, 2023 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (the “Company”, “Zefiro”, or “ZEFI”) and X Machina Capital Strategies (“XMC”) today announced that they will be co-hosting an...
Zefiro Methane Corp. Announces Presale of Certified Carbon Credits to Mercuria Energy America, LLC
13 juil. 2023 09h00 HE
|
Zefiro Methane Corp
VANCOUVER, British Columbia, July 13, 2023 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (the “Company”, “Zefiro”, or “ZEFI”) is pleased to announce that it has pre-sold a portion of its methane emission...